TGF-β3 Inhibits Antibody Production by Human B Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Jan 5

PMID 28052118

Citations 22

Authors

Yumi Tsuchida

Shuji Sumitomo

Kazuyoshi Ishigaki

Akari Suzuki

Yuta Kochi

Haruka Tsuchiya

Mineto Ota

Toshihiko Komai

Mariko Inoue

Kaoru Morita

Tomohisa Okamura

Kazuhiko Yamamoto

Keishi Fujio

Affiliations

Soon will be listed here.

Abstract

TGF-β is a pleotropic cytokine involved in various biological processes. Of the three isoforms of TGF-β, TGF-β1 has long been recognized as an important inhibitory cytokine in the immune system and has been reported to inhibit B cell function in both mice and humans. Recently, it has been suggested that TGF-β3 may play an important role in the regulation of immune system in mice. Murine CD4+CD25-LAG3+ regulatory T cells suppress B cell function through the production of TGF-β3, and it has been reported that TGF-β3 is therapeutic in a mouse model of systemic lupus erythematosus. The effect of TGF-β3 on human B cells has not been reported, and we herein examined the effect of TGF-β3 on human B cells. TGF-β3 suppressed B cell survival, proliferation, differentiation into plasmablasts, and antibody secretion. Although the suppression of human B cells by TGF-β1 has long been recognized, the precise mechanism for the suppression of B cell function by TGF-β1 remains elusive; therefore, we examined the effect of TGF-β1 and β3 on pathways important in B cell activation and differentiation. TGF-β1 and TGF-β3 inhibited some of the key molecules of the cell cycle, as well as transcription factors important in B cell differentiation into antibody secreting cells such as IRF4, Blimp-1, and XBP1. TGF-β1 and β3 also inhibited B cell receptor signaling. Our results suggest that TGF-β3 modifying therapy might be therapeutic in autoimmune diseases with B cell dysregulation in humans.

Citing Articles

TW01 Mitigates PM-Induced Lung Injury and Improves Gut Health in Mice.

Luo S, Chen M Nutrients. 2025; 17(5).

PMID: 40077701 PMC: 11901689. DOI: 10.3390/nu17050831.

Tang Y, Wang D, Chen Y, Xu W, Huang A Front Immunol. 2024; 14:1305590.

PMID: 38164134 PMC: 10757975. DOI: 10.3389/fimmu.2023.1305590.

Interactions between B cells and T follicular regulatory cells enhance susceptibility to Brucella infection independent of the anti-Brucella humoral response.

Dadelahi A, Abushahba M, Ponzilacqua-Silva B, Chambers C, Moley C, Lacey C PLoS Pathog. 2023; 19(9):e1011672.

PMID: 37721965 PMC: 10538787. DOI: 10.1371/journal.ppat.1011672.

Identification of immune-related signature with prognosis in children with stage 4 and 4S neuroblastoma.

Cao L, Liu Q, Ma Y, Wang S Clin Transl Oncol. 2023; 26(4):905-916.

PMID: 37709978 DOI: 10.1007/s12094-023-03320-4.

From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmune diseases.

Zhou X, Gu Y, Wang H, Zhou W, Zou L, Li S Inflamm Res. 2023; 72(6):1215-1235.

PMID: 37314518 DOI: 10.1007/s00011-023-01742-y.

References

Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

Van Vlasselaer P, Punnonen J, De Vries J . Transforming growth factor-beta directs IgA switching in human B cells. J Immunol. 1992; 148(7):2062-7. View

Finnson K, McLean S, Di Guglielmo G, Philip A . Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring. Adv Wound Care (New Rochelle). 2014; 2(5):195-214. PMC: 3857355. DOI: 10.1089/wound.2013.0429. View

Kee B, Rivera R, Murre C . Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat Immunol. 2001; 2(3):242-7. DOI: 10.1038/85303. View

Gugasyan R, Grumont R, Grossmann M, Nakamura Y, Pohl T, Nesic D . Rel/NF-kappaB transcription factors: key mediators of B-cell activation. Immunol Rev. 2000; 176:134-40. DOI: 10.1034/j.1600-065x.2000.00615.x. View

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

Dang H, Geiser A, Letterio J, Nakabayashi T, Kong L, Fernandes G . SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol. 1995; 155(6):3205-12. View

Dunker N, Krieglstein K . Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur J Biochem. 2000; 267(24):6982-8. DOI: 10.1046/j.1432-1327.2000.01825.x. View

Nakamura K, Kitani A, Strober W . Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 2001; 194(5):629-44. PMC: 2195935. DOI: 10.1084/jem.194.5.629. View

10.

Grumont R, Gerondakis S . Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med. 2000; 191(8):1281-92. PMC: 2193138. DOI: 10.1084/jem.191.8.1281. View

11.

Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S . TGF-β - an excellent servant but a bad master. J Transl Med. 2012; 10:183. PMC: 3494542. DOI: 10.1186/1479-5876-10-183. View

12.

Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S . TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015; 6:6329. PMC: 4346620. DOI: 10.1038/ncomms7329. View

13.

Lee Y, Awasthi A, Yosef N, Quintana F, Xiao S, Peters A . Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012; 13(10):991-9. PMC: 3459594. DOI: 10.1038/ni.2416. View

14.

Cerutti A, Zan H, Schaffer A, Bergsagel L, Harindranath N, Max E . CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol. 1998; 160(5):2145-57. PMC: 4624333. View

15.

Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

16.

Lawrie C, Shilling R, Troussard X, Cattan H, Mossafa H, Pezzella F . Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFbeta signalling pathways. Leukemia. 2008; 23(3):581-3. DOI: 10.1038/leu.2008.223. View

17.

Banchereau J, Pascual V, OGarra A . From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol. 2012; 13(10):925-31. PMC: 3609707. DOI: 10.1038/ni.2406. View

18.

Chikuma S, Suita N, Okazaki I, Shibayama S, Honjo T . TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol. 2012; 13(6):596-603. DOI: 10.1038/ni.2293. View

19.

Coffman R, Lebman D, Shrader B . Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med. 1989; 170(3):1039-44. PMC: 2189449. DOI: 10.1084/jem.170.3.1039. View

20.

Shull M, Ormsby I, Kier A, Pawlowski S, Diebold R, Yin M . Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992; 359(6397):693-9. PMC: 3889166. DOI: 10.1038/359693a0. View